Solana Company (HSDT) Stock

Solana Company (HSDT) is a Financials stock trading at $2.10 (as of 2026-08-21), with a market capitalization of $126.96M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.

Understand Solana Company: how it makes money

Solana Company is a neurotech medical device company focused on neurological wellness, developing and licensing non-invasive neuromodulation technologies including a portable tongue-delivered stimulator. It also reports revenue line items such as Staking Revenue and Other Revenue.

In the latest quarter, reported revenue is 0.0B while the company still records a deeply negative operating margin, implying the business is not yet showing revenue-based profitability.

Revenue by segment (latest quarter)
Staking$0.0B
Other$0.0B
Canada$0.0B

Business quality (Weak): Clear operating KPIs are provided, but the company mix of neurotech-focused adoption metrics and blockchain-like network metrics makes it harder to connect day-to-day activity to reported revenue, especially with revenue reported as 0.0B.

Bull case

  • Therapy access execution: Percentage of United States PONS Device Prescriptions Filled Through the Patient Therapy Access Program is 80%.
  • Program expansion signals: The company reports 36 clinics in Canada and 100.0 Physical Therapists Trained or Registered in the United States.

Bear case

  • No reported revenue in the latest quarter: Total revenue is 0.0B, and revenue line items including Staking Revenue and Other Revenue are each 0.0B.
  • Large operating losses: Operating margin is -2751.1%, indicating substantial operating expense relative to reported revenue.
Valuation — source: SEC EDGAR (first-party)
Price$2.10
Market Cap$126.96M
Price / Book0.77
Price / Sales10.52
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$6.02M
Net Margin-679.6%
Revenue Growth (YoY)5774.4%
EPS Growth (YoY)-99.5%
Financial Health — source: SEC EDGAR
Altman Z-Score16.92 (safe)
Valuation vs Sector & Industry
Sector P/E (Financials)15.1
Industry P/E (Banking)12.9
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderKathmere Capital Management, LLC ($7.95M)
Institutional Holders Tracked10
Company
SectorFinancials
IndustryBanking
CEODane Carl Andreeff
Employees21
CountryUS
IPO Date2014-06-27

Related Companies (Business model: Crypto Exchange / Custody / Staking; 8 closest by market cap; US-domiciled)

  • ProCap Financial, Inc. (BRR)
  • DeFi Technologies Inc. (DEFT)
  • USBC, Inc. (USBC)
  • DeFi Development Corp. (DFDV)
  • Axe Compute Inc. (AGPU)
  • SUI Group Holdings Limited (SUIG)
  • FORUM MARKETS Inc (FRMM)
  • Exodus Movement, Inc. (EXOD)
HSDT earnings history · HSDT institutional & insider holders · HSDT KPIs & operating metrics · HSDT financials · HSDT investor presentations & press releases · HSDT SEC filings · HSDT peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-21.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.